QLQ MY20

PDF / 175KB Download Provide Feedback

EORTC QLQ-MY20

The European Organisation for the Research and Treatment of Cancer Myeloma Module Quality of Life Questionnaire (EORTC QLQ-MY20) is a specialised tool designed to assess the quality of life in myeloma patients.

Developed by the European Organisation for Research and Treatment of Cancer (EORTC), this questionnaire is an extension of the broader EORTC QLQ-C30, specifically adapted to address the unique concerns and symptoms of myeloma patients. The EORTC QLQ-MY20 evaluates critical aspects of patients’ experiences, including disease symptoms, side effects of treatment, emotional well-being, and social functioning. It is a validated instrument frequently used in clinical trials and routine practice to ensure comprehensive assessment and to help healthcare providers better understand the impact of the disease and its treatment on patients’ daily lives.

Using the questionnaire in myeloma practice?

Find free similar tools, education and clinical updates to support your work on the HCP Hub.

By integrating this tool into clinical care, professionals can more effectively monitor and improve patient-centred treatment strategies.

Use Case

Type

Source

  • Other

You might also like

  • MyPOS

    MyPOS is a myeloma-specific version of the Palliative care Outcome Scale recently developed and validated to measure myeloma-specific quality of life issues and intended for use in clinical care.

  • Lawton Instrumental Activities of Daily Living Scale

    The Lawton Instrumental Activities of Daily Living (IADL) scale is designed to assess a person’s ability to perform more complex activities necessary for independent living within the community.

  • EORTC QLQ-C30

    This essential tool facilitates valuable insights into patients’ physical, emotional, and social well-being, ultimately supporting more informed treatment decisions and care strategies. By utilising the EORTC QLQ-C30, healthcare professionals can better understand the unique challenges faced by cancer patients and survivors, leading to tailored interventions that address their specific needs.